ArticleRheumatology international2024

Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.

Patrick-Pascal Strunz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.